References
- Beyer G, Hoffmeister A, Michl P, Gress TM, Huber W, Algül H et al. S3-Leitlinie Pankreatitis: Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). AWMF Registernummer 021 - 003 September 2021.
- Capurso G, Traini M, Piciucchi M, Signoretti M, Arcidiacono PG. Exocrine pancreatic insufficiency: prevalence, diagnosis, and management. Clin Exp Gastroenterol. 2019; 12:129–39.
- European Pharmacopeia (Ph. Eur.) 11.0, Monograph 0350, Pancreas Powder, BfArM, Bonn; 2023; 5407–5408.
- Fieker A, Philpott J, Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future. Clin Exp Gastroenterol. 2011; 4:55–73.
- Food Chemicals Codex (FCC), 8th ed.; The United States Pharmacopeial Convention: Rockville, MD, 2012.
- Geus WP, Eddes EH, Gielkens HA, Gan KH, Lamers CB, Masclee AA. Post-prandial intragastric and duodenal acidity are increased in patients with chronic pancreatitis. Aliment Pharmacol Ther. 1999; 13(7):937–43.
- Gollasch B, Dogan I, Rothe M, Gollasch M, Luft FC. Effects of hemodialysis on blood fatty acids Physiological Reports. 2020;8:e14332.
- Hoffmeister A, Mayerle J, Beglinger C, Büchler MW, Bufler P, Dathe K et al. S3-Leitlinie Chronische Pankreatitis: Definition, Ätiologie, Diagnostik, konservative, interventionell endoskopische und operative Therapie der chronischen Pankreatitis. Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS). Z Gastroenterol. 2012; 50(11):1176–224.
- Liu T, Dogan I, Rothe M, Reichardt J, Knauf F, Gollasch M, Luft FC, Gollasch B. Bioaccumulation of Blood Long-Chain Fatty Acids during Hemodialysis. Metabolites. 2022;12(3):269
- Löffler G, Petrides PE, Heinrich PC. Biochemie und Pathobiochemie. 8., völlig neu bearb. Aufl. 2007. Berlin, Heidelberg: Springer Berlin Heidelberg; 2007. (Springer-Lehrbuch).
- Löhr J-M, Hummel FM, Pirilis KT, Steinkamp G, Körner A, Henniges F. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency. Eur J Gastroenterol Hepatol. 2009; 21(9):1024–31.
- Maev IV, Kucheryavyy YA, Gubergrits NB, Bonnacker I, Shelest EA, Janssen-van Solingen GP et al. Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS. Drugs R D. 2020; 20(4):369–76.
- Moreau H, Gargouri Y, Lecat D, Junien JL, Verger R. Screening of preduodenal lipases in several mammals. Biochimica et Biophysica Acta (BBA) – Lipids and Lipid Metabolism 1988; 959(3):247–52.
- Nakamura T, Takeuchi T, Tando Y. Pancreatic dysfunction and treatment options. Pancreas. 1998; 16(3):329–36.
- Ogawa T. Effects of microbial digestive enzyme lipase on gastric digestion and absorption of lipid in rats. Digestion & Absorption. 1998; (21 (2)):12–5.
- Osterwald H. Zur Substitutionstherapie mit Verdauungsenzymen pflanzlicher und mikrobieller Herkunft. Deutsche Apotheker Zeitung. 1977; (43):1790–1794.
- Ovesen L, Bendtsen F, Tage-Jensen U, Pedersen NT, Gram BR, Rune SJ. Intraluminal pH in the stomach, duodenum, and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency. Gastroenterology. 1986; 90(4):958–62.
- Regan PT, Malagelada JR, Dimagno EP, Go VLW. Postprandial gastric function in pancreatic insufficiency. Gut. 1979; 20(3):249–54.
- Rehner G, Daniel H. Biochemie der Ernährung. Heidelberg: Spektrum Akad. Verl.; 1999. (Spektrum Lehrbuch).
- Shrikhande SV, Prasad VGM, Domínguez-Muñoz JE, Weigl KE, Sarda KD. In vitro Comparison of Pancreatic Enzyme Preparations Available in the Indian Market. Drug Des Devel Ther. 2021; 15:3835–43.